DENSE PELVIC ADHESIONS RECTUM, GRAVIDA 2 PARA 2(2002) CHRONIC CYCLIC PELVIC PAIN SECONDARY TO ADENOMYOSIS WITH BILATERAL ENDOMETRIOMA

Reading File
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

adenomyosis endometrioma pelvic pain management

Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
I now have comprehensive information from the textbooks. Let me compile a thorough clinical summary for this patient.

Clinical Summary: Dense Pelvic Adhesions, Adenomyosis with Bilateral Endometrioma

Patient Profile: Gravida 2 Para 2 (last delivery 2002) - Premenopausal woman with chronic cyclic pelvic pain

Overview of the Pathology

This patient has three overlapping but distinct pelvic pathologies that compound each other:

1. Adenomyosis

Adenomyosis is the presence of endometrial glands and stroma within the myometrium. The ectopic endometrial tissue responds cyclically to hormonal stimulation, causing the characteristic chronic cyclic pelvic pain pattern seen in this patient.
  • Presents as dysmenorrhea, heavy menstrual bleeding, and an enlarged, globular, tender uterus ("boggy uterus")
  • The diagnosis is suspected clinically and confirmed on imaging (transvaginal ultrasound or MRI) or histopathology
  • Parity and prior deliveries (as in this G2P2 patient) are associated with adenomyosis, as myometrial trauma during delivery may allow endometrial invasion
  • Hormonal management is the first-line treatment; definitive cure is hysterectomy
  • Robbins, Cotran & Kumar Pathologic Basis of Disease, p.930
  • Harrison's Principles of Internal Medicine 22E, p.3180

2. Bilateral Ovarian Endometriomas

Endometriosis affects approximately 10% of females in active reproductive life, most commonly in the third and fourth decades. Ovarian endometriomas ("chocolate cysts") are found in roughly one-third of women with endometriosis and are often bilateral, as in this patient.
Sites of endometriosis in descending order of frequency:
  1. Ovaries (bilateral in this patient)
  2. Uterine ligaments
  3. Rectovaginal septum
  4. Cul-de-sac
  5. Pelvic peritoneum
  6. Serosa of large/small bowel and appendix
  7. Cervix, vagina, fallopian tubes
  8. Laparotomy scars
The cyclic nature of this patient's pain is consistent with endometriosis, as ectopic implants respond to menstrual hormonal cycling, bleeding into enclosed spaces, and triggering inflammatory reactions.
  • Robbins, Cotran & Kumar, p.929
  • Schwartz's Principles of Surgery 11th Ed., p.1830

3. Dense Pelvic Adhesions Involving the Rectum

Dense adhesions are a direct consequence of endometriosis and its inflammatory environment. The rectovaginal septum and rectum are among the most common sites for deep infiltrating endometriosis (DIE). Pelvic adhesions in endometriosis result from:
  • Repeated cyclic bleeding from ectopic implants causing local inflammatory response
  • Organization of fibrin deposits into fibrous adhesions
  • Post-surgical adhesion formation from prior procedures
Clinical consequences of rectal involvement:
  • Painful defecation (dyschezia)
  • Hematochezia (cyclic rectal bleeding during menses)
  • Bowel cramping and constipation
  • Significant risk of bowel injury during surgical intervention
  • Berek & Novak's Gynecology, p.657-658
  • Schwartz's Principles of Surgery, p.1830

Diagnostic Approach

InvestigationRole
Transvaginal ultrasound (TVUS)First-line; identifies endometriomas (ground-glass echogenicity), adenomyosis (heterogeneous myometrium, myometrial cysts), non-mobile ovaries
Pelvic MRIHigher sensitivity/specificity for deep infiltrating endometriosis, bowel/rectal involvement, and adenomyosis extent
CA-125May be elevated; low negative predictive value - not diagnostic alone
Colonoscopy/rectal ultrasoundIf bowel involvement suspected (hematochezia, dyschezia)
Diagnostic laparoscopyGold standard for endometriosis diagnosis; allows staging and simultaneous treatment
Key note: The stage/severity of endometriosis at laparoscopy does not always correlate with the degree of pain - severe adhesions may cause debilitating pain while appearing less dramatic on imaging.

Management

Medical (Hormonal) Management - First Line

AgentMechanismEvidence
Combined oral contraceptives (COCs)Suppress ovulation, reduce ectopic implant stimulationEffective for dysmenorrhea and pain; continuous use preferred over cyclic for pain control
Continuous progestins (oral, implant, levonorgestrel IUD)Induce decidualization/atrophy of implantsWell-established for endometriosis and adenomyosis
GnRH agonists (leuprolide, buserelin) + add-back therapyHypoestrogenic state suppresses all implantsReserved for failure of first-line agents; add-back prevents bone loss
GnRH antagonists (elagolix)Same mechanism, faster on/offFDA-approved for endometriosis-associated pain
Aromatase inhibitorsBlock peripheral estrogen synthesisUsed in refractory cases
NSAIDsProstaglandin inhibitionUseful adjunct for dysmenorrhea
Levonorgestrel-IUDLocal progestin effect on endometrium/adenomyosisEffective for adenomyosis-related heavy bleeding and pain
Post-surgical medical therapy: Long-term postoperative OC use significantly reduces endometrioma recurrence. Cyclic OC users showed 36-month cumulative endometrioma-free rate of 94% vs. 51% in non-users after laparoscopic excision (p<0.001). - Berek & Novak's Gynecology, p.662

Surgical Management

Endometrioma Surgery

Laparoscopic cystectomy (excision of cyst wall) is preferred over drainage + ablation based on systematic review evidence:
  • Lower recurrence of dysmenorrhea (OR 0.15; 95% CI 0.06-0.38)
  • Lower recurrence of dyspareunia (OR 0.08; 95% CI 0.01-0.51)
  • Lower recurrence of non-menstrual pelvic pain (OR 0.10; 95% CI 0.02-0.56)
  • Lower rate of endometrioma recurrence (OR 0.41; 95% CI 0.18-0.93)
  • Reduced need for further surgery (OR 0.21; 95% CI 0.05-0.79)
ESHRE guidelines recommend cystectomy over drainage/coagulation. For very large endometriomas technically difficult to excise, a three-step procedure can be considered: marsupialization/rinsing → GnRH analog for 3 months → cyst wall electrocoagulation/vaporization.
  • Berek & Novak's Gynecology, p.656-657

Deep Endometriosis with Rectal/Bowel Adhesions - HIGH COMPLEXITY

This patient's dense pelvic adhesions to the rectum places her in the category of deep infiltrating endometriosis (DIE) with colorectal involvement - the most surgically demanding presentation:
  • Complete surgical excision of all lesions in a single procedure is recommended
  • Requires multidisciplinary team: gynecologist + colorectal surgeon + urologist on standby
  • Should be performed at a specialized referral center
  • Requires extensive preoperative counseling about risk of bowel injury, colostomy, and other complications
  • Preoperative MRI is mandatory to map bowel and urologic involvement
  • Preoperative ureteric stents placement may facilitate surgery
  • Options for bowel endometriosis: shaving, disc excision, or segmental bowel resection + anastomosis - the best approach is debated and individualized
  • Laparoscopy is preferred over laparotomy (less blood loss, fewer complications, higher pregnancy rates)
  • Berek & Novak's Gynecology, p.657-658

Adenomyosis Surgery

  • Hysterectomy is the only definitive cure - appropriate if patient has completed childbearing (she is G2P2 with no stated desire for more pregnancies)
  • Conservative surgical options (adenomyomectomy, endometrial ablation) have limited evidence

Definitive Management Consideration

Given that this patient is G2P2 with completed childbearing, bilateral endometriomas, adenomyosis, and dense rectal adhesions, serious consideration should be given to:
  • Total laparoscopic hysterectomy (TLH) ± bilateral salpingo-oophorectomy (BSO) - curative for adenomyosis and eliminates hormonal drive for endometriosis; bilateral salpingectomy at minimum recommended
  • Simultaneous adhesiolysis and cystectomy at time of definitive surgery
  • If bowel involvement is confirmed: colorectal resection with anastomosis may be required
  • Post-surgical hormone replacement therapy (HRT) strategy must be planned if BSO is performed in a premenopausal patient

Pain Management Considerations

  • NSAIDs for cyclic pain flares
  • Consultation with a pain specialist is appropriate - endometriosis pain can persist even after surgery due to central sensitization
  • The pattern of pain in endometriosis is complex and does not always respond to treatment - multidisciplinary pain management may be needed

Key Clinical Points for This Patient

  1. Bilateral endometriomas + adenomyosis creates a compounding pain burden - both require treatment
  2. Dense rectal adhesions significantly increase surgical complexity and risk - bowel prep and colorectal surgical backup are mandatory before any operative intervention
  3. Completed parity (G2P2) opens the door to definitive hysterectomy
  4. Cyclic pain pattern is consistent with hormonal dependence - supports medical suppression as a bridge to definitive surgery
  5. If medical management is attempted first: continuous COC or progestin-IUD are first steps; GnRH agonist + add-back for refractory cases
  6. Postoperative hormonal suppression reduces endometrioma recurrence even if hysterectomy is not performed

Recent Evidence (PubMed, 2024-2026):
  • A 2024 systematic review (PMID 39067674) examined functional determinants of uterine contractility in endometriosis and adenomyosis - uterine hypercontractility is now recognized as contributing to pain and infertility in these conditions
  • A 2024 meta-analysis (PMID 38733102) explored pathogenic models of endometriosis, reinforcing the multifactorial origin of the disease
This is a shared conversation. Sign in to Orris to start your own chat.